Literature DB >> 11696165

Fasciola hepatica cathepsin L cysteine proteinase suppresses Bordetella pertussis-specific interferon-gamma production in vivo.

S M O'Neill1, K H Mills, J P Dalton.   

Abstract

We have previously demonstrated that Fasciola hepatica infection significantly reduced Bordetella pertussis-specific interferon (IFN)-gamma production in mice coinfected with B. pertussis or immunized with a pertussis whole cell vaccine (Pw). In the present study, we have identified parasite molecules capable of mimicking this suppressive effect of F. hepatica. Parenteral injection of mice with culture medium in which adult F. hepatica were maintained (excretory/secretory, ES, products) suppressed B. pertussis-specific IFN-gamma production in mice immunized with Pw. The suppressive effect of ES was abrogated by coinjecting ES with the cysteine proteinase inhibitor, Z-Phe-Ala-diazomethylketone. Furthermore, purified cathepsin L proteinase (FheCL), a major component of ES products, was capable of suppressing IFN-gamma production. The suppressive effect of FheCL was attenuated in interleukin (IL)-4 defective (IL-4-/-) mice. Therefore, FheCL released by F. hepatica is involved in the suppression of Th1 immune responses and this suppression may be dependent upon IL-4.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696165     DOI: 10.1046/j.1365-3024.2001.00411.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  36 in total

1.  Comparison of modulation of sheep, mouse and buffalo lymphocyte responses by Fasciola hepatica and Fasciola gigantica excretory-secretory products.

Authors:  W Zhang; E Moreau; F Peigné; W Huang; A Chauvin
Journal:  Parasitol Res       Date:  2005-02-12       Impact factor: 2.289

Review 2.  Dendritic cells and parasites: from recognition and activation to immune response instruction.

Authors:  Claudia Cristina Motran; Laura Fernanda Ambrosio; Ximena Volpini; Daiana Pamela Celias; Laura Cervi
Journal:  Semin Immunopathol       Date:  2016-09-01       Impact factor: 9.623

3.  Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.

Authors:  Ivelisse Martin; Kimberly Cabán-Hernández; Olgary Figueroa-Santiago; Ana M Espino
Journal:  J Immunol       Date:  2015-03-16       Impact factor: 5.422

4.  Experimental Fasciola hepatica infection alters responses to tests used for diagnosis of bovine tuberculosis.

Authors:  Robin J Flynn; Celine Mannion; Olwen Golden; Orcun Hacariz; Grace Mulcahy
Journal:  Infect Immun       Date:  2006-12-28       Impact factor: 3.441

5.  Proteomic analysis of Fasciola hepatica excretory and secretory products (FhESPs) involved in interacting with host PBMCs and cytokines by shotgun LC-MS/MS.

Authors:  Qing Liu; Si-Yang Huang; Dong-Mei Yue; Jin-Lei Wang; Yujian Wang; Xiangrui Li; Xing-Quan Zhu
Journal:  Parasitol Res       Date:  2016-11-19       Impact factor: 2.289

6.  Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis.

Authors:  Nawal M Boukli; Bonnibel Delgado; Martha Ricaurte; Ana M Espino
Journal:  J Parasitol       Date:  2011-03-11       Impact factor: 1.276

Review 7.  Immunity against helminths: interactions with the host and the intercurrent infections.

Authors:  Emmanuelle Moreau; Alain Chauvin
Journal:  J Biomed Biotechnol       Date:  2010-02-03

8.  Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3.

Authors:  Sheila Donnelly; Sandra M O'Neill; Colin M Stack; Mark W Robinson; Lynne Turnbull; Cynthia Whitchurch; John P Dalton
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

Review 9.  Evasion of Host Immunity During Fasciola hepatica Infection.

Authors:  Robin J Flynn; Mayowa Musah-Eroje
Journal:  Methods Mol Biol       Date:  2020

10.  Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses.

Authors:  David J Dowling; Clare M Hamilton; Sheila Donnelly; James La Course; Peter M Brophy; John Dalton; Sandra M O'Neill
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.